|
1
|
Friedman SL: Evolving challenges in
hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 7:425–436.
2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang X, Cui JH, Meng QQ, Li SS, Zhou W
and Xiao S: Advance in anti-tumor mechanisms of shikonin, alkannin
and their derivatives. Mini Rev Med Chem. 18:164–172.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ma X, Yu M, Hao C and Yang W: Shikonin
induces tumor apoptosis in glioma cells via endoplasmic reticulum
stress, and Bax/Bak mediated mitochondrial outer membrane
permeability. J Ethnopharmacol. 263(113059)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Guo C, He J, Song X, Tan L, Wang M, Jiang
P, Li Y, Cao Z and Peng C: Pharmacological properties and
derivatives of shikonin-A review in recent years. Pharmacol Res.
149(104463)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nie Y, Yang Y, Zhang J, Cai G, Chang Y,
Chai G and Guo C: Shikonin suppresses pulmonary fibroblasts
proliferation and activation by regulating Akt and p38 MAPK
signaling pathways. Biomed Pharmacother. 95:1119–1128.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan
Q, Luo J, Zen K and Yang J: Inhibiting aerobic glycolysis
suppresses renal interstitial fibroblast activation and renal
fibrosis. Am J Physiol Renal Physiol. 313:F561–F575.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fan C, Dong Y, Xie Y, Su Y, Zhang X,
Leavesley D and Upton Z: Shikonin reduces TGF-β1-induced collagen
production and contraction in hypertrophic scar-derived human skin
fibroblasts. Int J Mol Med. 36:985–991. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang J, Wang Z and Chen DL: Shikonin
ameliorates isoproterenol (ISO)-induced myocardial damage through
suppressing fibrosis, inflammation, apoptosis and ER stress. Biomed
Pharmacother. 93:1343–1357. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang H and Zhang G: Activation of
CaMKKβ-AMPK-mTOR pathway is required for autophagy induction by
β,β-dimethylacrylshikonin against lung adenocarcinoma cells.
Biochem Biophys Res Commun. 517:477–483. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tian R, Li Y and Gao M: Shikonin causes
cell cycle arrest and induces apoptosis by regulating the
EGFR/NF-κB signaling pathway in human epidermoid carcinoma A431
cells. Biosci Rep. 35(e00189)2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wei Y, Li M, Cui S, Wang D, Zhang CY, Zen
K and Li L: Shikonin inhibits the proliferation of human breast
cancer cells by reducing tumor-derived exosomes. Molecules.
21(777)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng
Y, Lv J, Song Z, Li Y, Ji L, et al: Shikonin suppresses tumor
growth and synergizes with gemcitabine in a pancreatic cancer
xenograft model: Involvement of NF-κB signaling pathway. Biochem
Pharmacol. 88:322–333. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang L, Gai P, Xu R, Zheng Y, Lv S, Li Y
and Liu S: Shikonin protects chondrocytes from
interleukin-1beta-induced apoptosis by regulating PI3K/Akt
signaling pathway. Int J Clin Exp Pathol. 8:298–308.
2015.PubMed/NCBI
|
|
15
|
Wada N, Kawano Y, Fujiwara S, Kikukawa Y,
Okuno Y, Tasaki M, Ueda M, Ando Y, Yoshinaga K, Ri M, et al:
Shikonin, dually functions as a proteasome inhibitor and a
necroptosis inducer in multiple myeloma cells. Int J Oncol.
46:963–972. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shen M, Chen K, Lu J, Cheng P, Xu L, Dai
W, Wang F, He L, Zhang Y, Chengfen W, et al: Protective effect of
astaxanthin on liver fibrosis through modulation of TGF-β1
expression and autophagy. Mediators Inflamm.
2014(954502)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu XF, Un XF, Liu GH and Chen FF: Effects
of shikonin on the proliferation, migration and differentiation of
HaCaT cells mediated by IL-22. J Clin Dermatol. 43:215–218.
2014.
|
|
18
|
Qisen Li, Zeng J, Su M, He Y and Zhu B:
Acetylshikonin from Zicao attenuates cognitive impairment and
hippocampus senescence in D-galactose-induced aging mouse model via
upregulating the expression of SIRT1. Brain Res Bulletin.
137:311–318. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang H and Zhang G: Endoplasmic reticulum
stress-mediated autophagy protects against
β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma
cells. Cancer Sci. 109:1889–1901. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jing H, Sun W, Fan J, Zhang Y, Yang J, Jia
J, Li J, Guo J, Luo S and Zheng Y: Shikonin induces apoptosis of
HaCaT cells via the mitochondrial, Erk and Akt pathways. Mol Med
Rep. 13:3009–3016. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annual Rev Genet.
43:67–93. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mallat A, Lodder J, Teixeira-Clerc F,
Moreau R, Codogno P and Lotersztajn S: Autophagy: A multifaceted
partner in liver fibrosis. Biomed Res Int 2014: 869390, 2014.
urihttps://doi.org/10.1155/2014/869390simplehttps://doi.org/10.1155/2014/869390.
|
|
23
|
Zhang XW, Zhou JC, Peng D, Hua F, Li K, Yu
JJ, Lv XX, Cui B, Liu SS, Yu JM, et al: Disrupting the TRIB3-SQSTM1
interaction reduces liver fibrosis by restoring autophagy and
suppressing exosome-mediated HSC activation. Autophagy. 16:782–796.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liang H, Pan Z, Zhao X, Liu L, Sun J, Su
X, Xu C, Zhou Y, Zhao D, Xu B, et al: LncRNA PFL contributes to
cardiac fibrosis by acting as a competing endogenous RNA of let-7d.
Theranostics. 8:1180–1194. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lv XX, Wang XX, Li K, Wang ZY, Li Z, Lv Q,
Fu XM and Hu ZW: Rupatadine protects against pulmonary fibrosis by
attenuating PAF-mediated senescence in rodents. PLoS One.
8(e68631)2013.PubMed/NCBI View Article : Google Scholar
|
